Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick M Howard

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 9, 2024
Evaluation of cyclin-dependent kinase 4/6 inhibitor-induced serum creatinine elevations in patients with hormone receptor positive breast cancerEmily Ly, Frederick M Howard, Nan Chen, et al.
JAMA Oncology|February 23, 2023
Clinicopathologic Characteristics and Prognosis of ERBB2-Low Breast Cancer Among Patients in the National Cancer DatabaseDaniel S Peiffer, Fangyuan Zhao, Nan Chen, et al.
IEEE Transactions on Bio-Medical Engineering|April 19, 2022
Towards Patient-Specific Optimization of Neoadjuvant Treatment Protocols for Breast Cancer Based on Image-Guided Fluid DynamicsChengyue Wu, David A Hormuth, Guillermo Lorenzo, et al.
Journal of Applied Clinical Medical Physics|December 28, 2025
K-means clustering-based analysis of quantitative ultrafast DCE-MRI for predicting breast cancer response to neoadjuvant chemotherapyZhen Ren, Xiaobing Fan, Milica Medved, et al.
Breast Cancer Research and Treatment|April 29, 2023
The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancerElizabeth Terman, Jori Sheade, Fangyuan Zhao, et al.
Research Square|March 30, 2023
The Impact of Race and Age on Response to Neoadjuvant Therapy and Long-Term Outcomes in Black and White Women with Early-Stage Breast CancerElizabeth Terman, Jori Sheade, Fangyuan Zhao, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 14, 2024
Retrospective evaluation of adjuvant capecitabine dosing patterns in triple negative breast cancerKun Lin, Elena Michaels, Eric Polley, et al.
Breast Cancer Research and Treatment|September 5, 2022
Highly accurate response prediction in high-risk early breast cancer patients using a biophysical simulation platformFrederick M Howard, Gong He, Joseph R Peterson, et al.
BMC Bioinformatics|March 28, 2024
Slideflow: deep learning for digital histopathology with real-time whole-slide visualizationJames M Dolezal, Sara Kochanny, Emma Dyer, et al.
JAMA Network Open|February 3, 2026
Adjuvant Chemotherapy Use for Hormone Receptor-Positive, ERBB2-Negative Breast Cancer After RxPONDER TrialJincong Q Freeman, Poornima Saha, Daniel S Peiffer, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 9, 2024
Evaluation of cyclin-dependent kinase 4/6 inhibitor-induced serum creatinine elevations in patients with hormone receptor positive breast cancerEmily Ly, Frederick M Howard, Nan Chen, et al.
JAMA Oncology|February 23, 2023
Clinicopathologic Characteristics and Prognosis of ERBB2-Low Breast Cancer Among Patients in the National Cancer DatabaseDaniel S Peiffer, Fangyuan Zhao, Nan Chen, et al.
IEEE Transactions on Bio-Medical Engineering|April 19, 2022
Towards Patient-Specific Optimization of Neoadjuvant Treatment Protocols for Breast Cancer Based on Image-Guided Fluid DynamicsChengyue Wu, David A Hormuth, Guillermo Lorenzo, et al.
Journal of Applied Clinical Medical Physics|December 28, 2025
K-means clustering-based analysis of quantitative ultrafast DCE-MRI for predicting breast cancer response to neoadjuvant chemotherapyZhen Ren, Xiaobing Fan, Milica Medved, et al.
Breast Cancer Research and Treatment|April 29, 2023
The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancerElizabeth Terman, Jori Sheade, Fangyuan Zhao, et al.
Research Square|March 30, 2023
The Impact of Race and Age on Response to Neoadjuvant Therapy and Long-Term Outcomes in Black and White Women with Early-Stage Breast CancerElizabeth Terman, Jori Sheade, Fangyuan Zhao, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 14, 2024
Retrospective evaluation of adjuvant capecitabine dosing patterns in triple negative breast cancerKun Lin, Elena Michaels, Eric Polley, et al.
Breast Cancer Research and Treatment|September 5, 2022
Highly accurate response prediction in high-risk early breast cancer patients using a biophysical simulation platformFrederick M Howard, Gong He, Joseph R Peterson, et al.
BMC Bioinformatics|March 28, 2024
Slideflow: deep learning for digital histopathology with real-time whole-slide visualizationJames M Dolezal, Sara Kochanny, Emma Dyer, et al.
JAMA Network Open|February 3, 2026
Adjuvant Chemotherapy Use for Hormone Receptor-Positive, ERBB2-Negative Breast Cancer After RxPONDER TrialJincong Q Freeman, Poornima Saha, Daniel S Peiffer, et al.
Pageof 6